课题基金 / 基金详情

Building a platform to understand asymptomatic and symptomatic visceral leishmaniasis in Ethiopia

Building a platform to understand asymptomatic and symptomatic visceral leishmaniasis in Ethiopia
建立一个平台来了解埃塞俄比亚的无症状和有症状内脏利什曼病
批准号:
MR/R021600/1
负责人:
Pascale Kropf
金额:
$19.29万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --

项目摘要

项目成果

Pascale Kropf的其他基金

相似基金

相关文献

中文摘要
翻译
内脏利什曼病(VL)是一种由多诺瓦利什曼原虫引起的寄生虫病。它是最被忽视的热带病之一,影响到最贫穷的人口,对他们来说,不易获得诊断和有效治疗。在埃塞俄比亚,有320多万人生活在该病流行的地区,因此面临感染多诺瓦氏乳杆菌的风险。虽然大多数感染多诺瓦氏乳杆菌的个体没有任何症状,因此被指定为无症状;有些人患上了一种疾病,如果不及时治疗,几乎总是致命的。目前尚不清楚为什么有些人可以控制感染并保持无症状,而另一些人则发展为进行性无法愈合的VL。我们的目的是确定与无症状个体中寄生虫复制控制或VL患者中不受控制的寄生虫复制和功能失调免疫反应相关的独特免疫和基因表达特征。为此,我们在埃塞俄比亚西北部Metema-Humera地区确定了一个独特的个体种群:这是埃塞俄比亚最重要的VL流行焦点,占该国VL负担的60%。在这个地区,在6月至10月期间,激烈的季节性农业活动吸引了大约25万名农民工,用于除草和收获。这些季节工大多数来自无利什曼病地区,并前往利什曼病普遍存在的Metema-Humera地区从事季节工。这些移徙工人感染利什曼原虫的风险较高,因为他们在经常接触传播利什曼原虫的白蛉的地区生活和工作。这些农场的环境和工作条件极其恶劣,因此,对这些农民工的研究很少,对他们的生活方式和他们的旅行和工作习惯知之甚少。因此,我们在此提出一项概念验证研究,以证明我们可以:-招募足够数量的农民工,并在农业季节期间和之后跟踪他们。-通过不同的免疫学、血清学和分子检测,确定感染多诺瓦氏L.寄生虫的人。-在我们访问农场期间采集血液并将其储存,并将其运输到距离农场200公里的我们的实验室,发送到英国进行全基因组宿主基因表达的量化;以及在这个农场进行基本的功能分析。生成初步的流行病学、免疫学和基因表达数据,以确定与无症状感染或VL疾病相关的免疫特征。这项工作的结果将作为计划在Metema-Humera领域开展更大规模研究的基础,以确定无症状感染或VL发展的每个阶段的免疫学和基因表达特征。这对于制定预防和治疗利什曼病的新战略至关重要。
英文摘要
Visceral leishmaniasis (VL) is a parasitic disease caused by Leishmania (L.) donovani. It is one of the most neglected tropical diseases, affecting the poorest populations, for whom access to diagnosis and effective treatment is not readily accessible. In Ethiopia, over 3.2 million people live in areas where this disease is endemic and are therefore at risk of infection with L. donovani. While the majority of individuals infected with L. donovani show no symptoms and are therefore designated as asymptomatic; some develop a disease that, if left untreated, is almost always fatal. It is not understood why some individuals can control infection and stay asymptomatic whereas others develop progressive non-healing VL. Our aim is to identify distinct immunological and gene expression signatures that are associated with the control of parasite replication in asymptomatic individuals or uncontrolled parasite replication and dysfunctional immune responses in VL patients. To do this, we have identified a unique population of individuals in Northwest Ethiopia, in the Metema-Humera area: this is the most important endemic focus of VL in Ethiopia and accounts for 60% of the VL burden in the country. In this area, during the months of June to October, the intense seasonal agricultural activities attract >250,000 migrant workers, for weeding and harvest. The majority of these seasonal labourers come from leishmaniasis-free areas and travel for seasonal work to the Metema-Humera area where leishmaniasis is widespread. These migrant workers are at higher risk of being infected by Leishmania parasites as they live and work in areas where they are constantly being exposed to the sandflies that transmit Leishmania parasites. The environment and working conditions on these farms are extremely harsh and therefore, few studies have been made of these migrant workers, little is known about their lifestyle and their travelling and working habits. Therefore, here we propose a proof of concept study to demonstrate that we can:- Recruit sufficient numbers of migrant workers and follow them during and after the agricultural season.- Identify those who have been infected with L. donovani parasites by using different immunological, serological and molecular tests.- Collect blood and store it during our visits to the farm, transport it to our laboratory, 200km away from the farm, to send to the UK to quantify genome-wide host gene expression; as well as perform basic functional assay on this farm.- Generate preliminary epidemiological, immunological and gene expression data to identify immune signatures associated with either asymptomatic infection or VL disease. The results of this work will serve as a foundation to plan a larger study in the Metema-Humera area to identify immunological and gene expression signatures of each stage of the development of asymptomatic infection or VL. This will be essential for the development of new strategies to prevent and treat leishmaniasis.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1128/mbio.00971-21
发表时间: 2021-06-29
期刊: mBio
影响因子: 6.4
作者: [Franssen SU, Takele Y, Adem E, Sanders MJ, Müller I, Kropf P, Cotton JA]
通讯作者: Cotton JA
A Way Straight-Forward for Leishmania Genetics.
利什曼原虫遗传学的一种直接方法。
DOI: 10.1016/j.pt.2020.07.005
发表时间: 2020
期刊: Trends in parasitology
影响因子: 9.6
作者: [Cotton JA]
通讯作者: Cotton JA
Understanding differences in clinical presentations of cutaneous leishmaniasis in an endemic disease focus
  • 批准号:
    MR/R01020X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $54.31万
  • 财政年份:
    2018
  • 负责人:
    Pascale Kropf
  • 依托单位:
国内基金
海外基金
Data-driven Recommendation System Construction of an Online Medical Platform Based on the Fusion of Information